CoChat
Cited by 174

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial

Open access
Huttner, B.D., de Lastours, V., Wassenberg, M., Maharshak, N., Mauris, A., Galperine, T., Zanichelli, V., Kapel, N., Bellanger, A., Olearo, F., Duval, X., Armand-Lefevre, L., Carmeli, Y., Bonten, M., Fantin, B., Harbarth, S., Colle, L., Kloosterman, F., van Bentum-Puijk, W., Vlooswijk, J., Andremont, A., Ben Hayoun, M., Canoui, E., Chabrol, A., Gamany, N., Lafaurie, M., Lefort, A., Lepeule, R., Louis, Z., Rondinaud, E., Sadou Yayé, H., Sarfati, L., Zarrouk, V., Brossier, C., Carrez, L., Lazarevic, V., Renzi, G., von Dach, E., Cohen Percia, S., Shvartz, R., Lellouche, J. · 2019 · Clinical Microbiology and Infection

Abstract

OBJECTIVES: Intestinal carriage with extended spectrum β-lactamase Enterobacteriaceae (ESBL-E) and carbapenemase-producing Enterobacteriaceae (CPE) can persist for months. We aimed to evaluate whether oral antibiotics followed by faecal microbiota transplantation (FMT) can eradicate intestinal carriage with ESBL-E/CPE. METHODS: IU 4×/day; neomycin sulphate 500 mg 4×/day) followed by frozen FMT obtained from unrelated healthy donors. The primary outcome was detectable intestinal carriage of ESBL-E/CPE by stool culture 35-48 days after randomization (V4). ClinicalTrials.govNCT02472600. The trial was funded by the European Commission (FP7). RESULTS: Thirty-nine patients (G = 14; P = 16; U = 7; T = 2) colonized by ESBL-E (n = 36) and/or CPE (n = 11) were enrolled between February 2016 and June 2017. In the intention-to-treat analysis 9/22 (41%) patients assigned to the intervention arm were negative for ESBL-E/CPE at V4 (1/22 not receiving the intervention imputed as positive) whereas in the control arm 5/17 (29%) patients were negative (one lost to follow up imputed as negative) resulting in an OR for decolonization success of 1.7 (95% CI 0.4-6.4). Study drugs were well tolerated overall but three patients in the intervention group prematurely stopped the study antibiotics because of diarrhoea (all received FMT). CONCLUSIONS: Non-absorbable antibiotics followed by FMT slightly decreased ESBL-E/CPE carriage compared with controls; this difference was not statistically significant, potentially due to early trial termination. Further clinical investigations seem warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmi.2018.12.009

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 174

Metadata

Authors
Huttner, B. D., de Lastours, V., Wassenberg, M., Maharshak, N., Mauris, A., Galperine, T., Zanichelli, V., Kapel, N., Bellanger, A., Olearo, F., Duval, X., Armand-Lefevre, L., Carmeli, Y., Bonten, M., Fantin, B., Harbarth, S., Colle, L., Kloosterman, F., van Bentum-Puijk, W., Vlooswijk, J., Andremont, A., Ben Hayoun, M., Canoui, E., Chabrol, A., Gamany, N., Lafaurie, M., Lefort, A., Lepeule, R., Louis, Z., Rondinaud, E., Sadou Yayé, H., Sarfati, L., Zarrouk, V., Brossier, C., Carrez, L., Lazarevic, V., Renzi, G., von Dach, E., Cohen Percia, S., Shvartz, R., & Lellouche, J.
Venue
Clinical Microbiology and Infection
Publisher
Elsevier BV
Published
2019-07
Volume
25
Issue
7
Pages
830-838
ISSN
1198-743X (ISSN-L)
OpenAlex
W2906871753
Cited by
174
References
6
FWCI
7.73
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial. https://app.cochat.ai/papers/10.1016/j.cmi.2018.12.009
The paper
Huttner, B. D., de Lastours, V., Wassenberg, M., Maharshak, N., Mauris, A., Galperine, T., Zanichelli, V., Kapel, N., Bellanger, A., Olearo, F., Duval, X., Armand-Lefevre, L., Carmeli, Y., Bonten, M., Fantin, B., Harbarth, S., Colle, L., Kloosterman, F., van Bentum-Puijk, W., . . . Lellouche, J. (2019). A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2018.12.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.